Whistleblower kickback case against Alpharma results in $42.5 million recovery for U.S. and statesMarch 30, 2010 | Jeffrey NewmanWASHINGTON, March 17 -- Alpharma Inc. has agreed to pay $42.5 million to the federal government and certain states to settle a whistleblower lawsuit that exposed an alleged kickback scheme by the pharmaceutical company to boost its sales of Kadian, a prescription painkiller.
U.S. Files Suit Against Johnson & Johnson for Paying Kickbacks to Nation?s Largest Nursing Home PharmacyMarch 30, 2010 | Jeffrey NewmanThe United States has filed a civil False Claims Act complaint against drug manufacturer Johnson & Johnson (J&J) of New Brunswick, N.J., and two of its subsidiaries, Ortho-McNeil-Janssen Pharmaceuticals Inc. and Johnson & Johnson Health Care Systems Inc., the Justice Department announced today
Chevron agrees to $45 M settlement of natural gas royalties disputeMarch 30, 2010 | Jeffrey NewmanChevron has agreed to pay $45.5 million to settle claims that it violated the False Claims Act by knowingly underpaying royalties it owed on natural gas produced from federal and Indian leases.
KUWAITI CONTRACTOR NEGOTIATING SETTLEMENT WITH US GOVERNMENTMarch 30, 2010 | Jeffrey NewmanA leading Kuwaiti firm indicted for fraud in connection with multibillion dollar contracts with the U.S. Army said Dec. 28 it is in talks with U.S. authorities for an out-of-court settlement.
Qui Tam Suit Against University Nets $78.5 Million SettlementMarch 30, 2010 | Jeffrey NewmanA team of Bay Area plaintiffs lawyers struck a $78.5 million deal in a long-running false claims suit that accused the University of Phoenix of rewarding recruiters for enrolling students, according to a settlement agreement announced Monday.
Major False Claims Act Cases Resolved In Fiscal Year 2009March 30, 2010 | Jeffrey NewmanPfizer to Pay Record Payment of $2.4 billion This is the largest FCA recovery in history. Of the $2.3 billion settlement, $1.3 billion is a criminal fine and forfeiture related to the fraudulent off-label marketing of Bextra. This $1.3 billion criminal fine is the largest ever imposed in the U.S. . According to the settlement agreement on this case, Pfizer illegally promoted the sale and use of Bextra for a variety of conditions including acute pain and various types of surgical pain and at dosages other than for which its use was approved by the Food and Drug Administration. In addition, the company offered and paid illegal remuneration to health care professionals to induce them to promote and prescribe Bextra. A whistleblower on the claim, a Gulf War Veteran, and former Pfizer sales rep will earn more than $51.5 million as a result of his whistleblower lawsuit against Pfizer.